SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform

A key in controlling the SARS-CoV-2 pandemic is the assessment of the immune status of the population. We explored the utility of SARS-CoV-2 virus-like particles (VLPs) as antigens to detect specific humoral immune reactions in an enzyme-linked immunosorbent assay (ELISA). For this purpose, SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirschberg, Stefan, Bauer, Hannes, Kamhieh-Milz, Julian, Ringel, Frauke, Harms, Christoph, Eddin, Omar Kamal, Pruß, Axel, Hanack, Katja, Schulze-Forster, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774516/
https://www.ncbi.nlm.nih.gov/pubmed/36546901
http://dx.doi.org/10.3390/antib11040076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774516/
https://www.ncbi.nlm.nih.gov/pubmed/36546901
http://dx.doi.org/10.3390/antib11040076

Ejemplares similares